"One Call Does it All®" Call Today!
1-800-INJURED
se habla español
310-641-3335

Xarelto Lawsuit

Xarelto boxAccording to Reuters news wire, the first Xarelto lawsuit was filed in June 2014. The plaintiff, Virginia Stunteneck, made her claim in the U.S. District Court of the Eastern District of Pennsylvania. She had been hospitalized with uncontrollable gastrointestinal bleeding following her use of the anticoagulant drug Xarelto in 2013. The Xarelto lawsuit stated that the risks associated with the drug were not clear in the product labeling at the time. Furthermore, the plaintiff contended that the defendants were negligent in manufacturing and marketing such a drug that lacked an antidote to reverse its effects should uncontrolled bleeding occur.

Product liability attorneys from Ellis Law are bracing for many similar claims in the coming months. According to the Institute for Safe Medicine Practices, there were 680 adverse events filed for Xarelto in the first quarter of 2013 alone. Bleeding occurs in approximately 15 percent of patients with atrial fibrillation who take the drug for a year, the group reported. No settlements or court cases have reached a resolution yet, but the makers of a similar drug – Boehringer Ingelheim’s Pradaxa – have already settled thousands of claims.

Filing a Xarelto lawsuit with Ellis Law can help victims of personal injury seek justice and cover expensive, unanticipated medical treatments.

Family members who have lost a loved one to Xarelto bleeding can receive compensation for lost companionship, emotional distress and suffering, as well as wrongful death / funerary benefits. While there are no guarantees, it is not uncommon to see settlement offers or jury verdicts reach sums in the tens of millions. Our vast experience in the field of personal injury litigation will give you the leverage you need to reach peace of mind.

Injuries linked to Xarelto

RXList.com reports that “bleeding complications, including major bleeding events” are the most common adverse reactions associated with Xarelto. They go on to say that “Fainting, itching, and muscle spasms have been reported.”

Users should contact emergency personnel at once if they exhibit:

  • Easy bruising
  • Unusual bleeding (from the nose, mouth, or genitals)
  • Dizziness and nausea
  • Black stools, and
  • Numbness, weakness, or loss of movement in any body part

Though Xarelto doesn’t require patients to watch their diets and studies show Xarelto is more cost-effective than other anticoagulants for joint replacement, atrial fibrillation and thromboembolism, there is one major drawback.

Unlike older drugs like Coumadin (warfarin), newer anticoagulants like Pradaxa and Xarelto fail to have a working antidote, should patients experience sudden, uncontrolled bleeding. Xarelto lawsuits call attention to the fact that hospitals and doctors were not told of this fact in advance, leaving them ill-prepared to deal with potentially life-threatening situations.

FDA expresses wariness of Xarelto bleeding risks

Xarelto gained FDA approval for the prevention of deep vein thrombosis and pulmonary embolism in July, 2011. The indications were expanded to include the prevention of stroke in atrial fibrillation patients in November of that same year.

In light of recent Xarelto lawsuits, the FDA has not issued a formal statement, but they have said that the research does not paint a clear picture of the risks associated with the product — and, therefore, they cannot endorse new indications for the drug.

Furthermore, the FDA wrote Janssen Pharmaceuticals a letter stating that they needed to communicate the “risks of an increased risk of thrombotic events when the drug was discontinued without an adequate alternative anticoagulant and of decreased efficacy when not taken with the evening meal.”

Xarelto attorneys offer much-needed assistance to plaintiffs

Individuals who believe they have been harmed by Xarelto (and their families) are able to file Xarelto lawsuits on their own if they are willing to pay the $500 filing fee, study all the supplemental forms that are required, and represent themselves in court. It can be a long, arduous road from the day of filing to a final resolution. Often, it takes more than a year. Meanwhile, you’ll be subjected to every stall tactic in the book from well-heeled defendants.

Ellis Law attorneys will cover all aspects of litigation for you, from the filing fees and paperwork, to the representation of your best interests in court or out-of-court settlement negotiations. We’ll keep you posted with a timeline every step of the way, so you never feel “forgotten about” or left in the dark. Our in-depth knowledge of product liability law helps us find the best angle to present your case and connects you with leading medical experts who will testify on your behalf. We’ll garner all the evidence needed to substantiate your case and craft the soundest arguments in front of a jury. Best of all, you only pay legal fees if your case wins a settlement or jury verdict.

Ellis Law personal injury lawyers can help

Ellis Law has more than 20 years of experience in recovering personal injury verdicts and settlements. We understand the sensitive nature of these cases and lend a compassionate ear during your time of need. While we cannot undo the damage done by the manufacturers of Xarelto, we can help you win compensation to cover your medical expenses and assuage some of your suffering.

In the last five years alone, we have secured over $100 million for our clients. Our law firm accepts Xarelto lawsuit cases from around the country. Call 1-800-INJURED for a free consultation today.

  1. Reuters – Bayers Faces Lawsuits Over Xarelto http://www.reuters.com/article/2014/06/14/us-bayer-suit-idUSKBN0EP0HW20140614
  2. Reuters - Reports of side-effects from Bayer's Xarelto grow: Spiegel http://www.reuters.com/article/2013/09/08/us-bayer-xarelto-idUSBRE9870AH20130908
  3. RXList – Xarelto Side Effects http://www.rxlist.com/xarelto-side-effects-drug-center.htm
  4. Pharmacy Practice News - Rivaroxaban Beats Injectable on Cost-Effectiveness http://www.pharmacypracticenews.com/ViewArticle.aspx?d=Operations%2B%26%2BManagement&d_id=53&i=July+2014&i_id=1088&a_id=27783
  5. Forbes - FDA Once Again Rejects New Indication For Johnson & Johnson's Xarelto http://www.forbes.com/sites/larryhusten/2014/02/14/fda-once-again-rejects-new-indication-for-johnson-johnsons-xarelto/